Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Dublin, Feb. 17, 2017 -- Research and Markets has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Regenerative Medicine in US$ Million.
The report profiles 52 companies including many key and niche players such as
- AlloSource (US)
- Anika Therapeutics, Inc. (US)
- Bioventus LLC (US)
- DePuy Synthes Companies (US)
- DePuy Synthes Spine, Inc. (US)
- Exactech, Inc. (US)
- Integra LifeSciences Holdings Corp. (US)
- LifeNet Health, Inc. (US)
- Medtronic, plc (Ireland)
- NovaBone Products LLC (US)
- NuVasive, Inc. (US)
- Orthofix International N.V. (Netherlands)
- Osiris Therapeutics, Inc. (US)
- Smith & Nephew plc (UK)
- Stryker Corporation (US)
- Wright Medical Technology, Inc. (US)
- Zimmer Biomet Holdings, Inc. (US)
Key Topics Covered:
1. Outlook
2. Regenerative Medicine A Macro Perspective
3. Bone And Joint Regenerative Medicine An Overview
4. Competitive Landscape
5. Regenerative Medicine In Other Areas
6. Regulatory Environment
7. A Peek Into The Global Orthopedic Industry
8. Product Overview
9. Product Innovations/Introductions
10. Recent Industry Activity
11. Focus On Select Players
12. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 54)
- The United States (37)
- Canada (3)
- Japan (1)
- Europe (10)
- Germany (2)
- The United Kingdom (2)
- Rest of Europe (6)
- Asia-Pacific (Excluding Japan) (1)
- Middle East (1)
- Africa (1)
For more information about this report visit http://www.researchandmarkets.com/research/zzvd55/regenerative
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals
